Ulipristal acetate for treatment of symptomatic uterine fibroids and myoma-related hypermenorrhea
نویسندگان
چکیده
mone-sensitive tumors arising from smooth muscles and occurring in 20 to 40% of women of reproductive age (1, 2). This means that they are the most common benign uterine tumors in women of reproductive age. The most common concomitant symptoms are menorrhagia and iron deficiency anaemia, which in some cases cannot be treated adequately by iron substitution (3-5). Heavy menstrual bleeding means that the women have to consult their doctors and be absent from work Thomas Rabe (leading author), in cooperation with working group "Drug-based therapy of myoma and hypermenorrhea" (alphabetical order): Hans-Joachim Ahrendt, Christian Albring, Johannes Bitzer, Philippe Bouchard, Ulrich Cirkel, Christian Egarter, Klaus König, Werner Harlfinger, Matthias Matzko, Alfred Mueck, Thomas Römer, Thoralf Schollmeyer, Peter Sinn, Thomas Strowitzki, Hans-Rudolf Tinneberg, Markus Wallwiener, Rudy Leon de Wilde Ulipristal acetate for treatment of symptomatic uterine fibroids and myoma-related hypermenorrhea
منابع مشابه
Clinical utility of ulipristal acetate for the treatment of uterine fibroids: current evidence
Uterine myoma is the most common benign uterine tumor in women of reproductive age and occurs in 20%-25% of the worldwide population. No currently approved medical treatment is able to completely eliminate fibroids. Surgery, particularly hysterectomy, predominates as the treatment strategy of choice, even though it is associated with risks and complications and causes infertility. Until recentl...
متن کاملExpulsion of a uterine myoma in a patient treated with ulipristal acetate
Description of a spontaneous expulsion of a submucosal myoma in a patient treated with ulipristal acetate.
متن کاملUlipristal acetate before high complexity endoscopic (hysteroscopic, laparoscopic) myomectomy – a mini-review
Uterine myomas (fibromas, leiomyomas) are the most common tumours in women, and their clinical signs and symptoms are presented by 25-40% of patients with these benign tumours. According to current guidelines, the armamentarium for myoma management consists of: medical therapy (GnRH, SPRMs), non-surgical alternatives including uterine artery embolisation (UAE), vaginal temporary occlusion of ut...
متن کاملErratum to: Update of Conservative Systemic Treatment of Uterine Fibroids
Uterine fibroids are a common disease in women and lead to different symptoms, like pain and bleeding disorders. Apart from surgical treatment, there are many medical treatment options, which are presented in this article. Combined oral contraceptives and Levonorgestrel-releasing intrauterine systems are possible options for bleeding disorders that are a consequence of uterine fibroids. Gonadot...
متن کاملUlipristal acetate versus placebo for fibroid treatment before surgery.
BACKGROUND The efficacy and safety of oral ulipristal acetate for the treatment of symptomatic uterine fibroids before surgery are uncertain. METHODS We randomly assigned women with symptomatic fibroids, excessive uterine bleeding (a score of >100 on the pictorial blood-loss assessment chart [PBAC, an objective assessment of blood loss, in which monthly scores range from 0 to >500, with highe...
متن کامل